News
Aurinia Pharmaceuticals Announces Presentations at American College of Rheumatology (ACR) Convergence 2022
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the trajectory of autoimmune disease, today
Aurinia Announces European Commission Approval of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the trajectory of autoimmune disease, announced
Granite REIT Declares Distribution for September 2022
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2583 per stapled unit for the month of
CI Financial Reports Total Assets of $345.9 Billion for August 2022
CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today reported preliminary total assets of $345.9 billion as at August 31, 2022, consisting of asset management assets of $119.0 billion, Canadian
CI Global Asset Management Announces September 2022 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month or quarter ending September 30, 2022 in respect of the CI ETFs. In all cases, the distribution
CI Global Asset Management launches CI Alternative Multi-Strategy Fund
CI Global Asset Management (“CI GAM”) today announced the launch of CI Alternative Multi-Strategy Fund (the “Fund”), which provides investors with convenient one-stop access to CI GAM’s suite of
CI Global Asset Management Files Preliminary Prospectus for CI Auspice Broad Commodity ETF
CI Global Asset Management (“CI GAM”) announces it has filed and obtained a receipt for a preliminary prospectus for CI Auspice Broad Commodity ETF (“CCOM”).
“In today’s environment, exposure to
CI Financial Partners With CGI to Implement Advanced Transfer Agency Solution and Operations
CGI (TSX: GIB.A) (NYSE: GIB) and CI Financial Corp. (TSX: CIX; NYSE: CIXX) have entered into a long-term strategic partnership under which CGI will transform CI’s investment fund transfer agency
Granite REIT Declares Distribution for August 2022
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2583 per stapled unit for the month of
CI Global Asset Management Announces August 2022 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending August 31, 2022 in respect of the CI ETFs. In all cases, the distribution will be paid
CI Financial Reports Total Assets of $348.5 Billion for July 2022
CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today reported preliminary total assets of $348.5 billion as at July 31, 2022, consisting of asset management assets of $121.5 billion, Canadian
SunOpta Announces Second Quarter 2022 Financial Results
SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a U.S.-based global pioneer fueling the future of sustainable, plant-based and fruit-based foods and beverages, today announced
Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the second quarter ended June 30, 2022. Amounts, unless specified otherwise, are
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, announced that
Aurinia Pharmaceuticals Notification Regarding Inter Partes Patent Review
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today received notice regarding the U.S. Patent Office (USPTO) Patent Trial and Appeal Board (PTAB) decision to institute
Securityholder Early Warning News Release
CI Global Asset Management (“CI GAM”; the “Investment Manager”) reported today historical transactions as outlined below.
On April 12, 2022, CI GAM disposed of, on behalf of accounts and
Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that it will release financial and operational results for the second quarter of 2022 on Thursday, August 4
Aurinia Announces Positive CHMP Opinion for LUPKYNIS® (voclosporin) for the Treatment of Adults with Active Lupus Nephritis in Europe
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced
SunOpta Inc. Schedules Second Quarter 2022 Financial Results Release and Conference Call
SunOpta Inc. ("SunOpta") (Nasdaq:STKL) (TSX:SOY) a U.S.-based, global pioneer fueling the future of sustainable, plant-based and fruit-based food and beverages, today announced that it will issue
CI Financial Reports Total Assets of $333.7 Billion for June 2022
CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today reported preliminary total assets of $333.7 billion as at June 30, 2022, consisting of asset management assets of $116.1 billion, Canadian
CI Financial Announces Second Quarter Earnings Conference Call and Webcast
CI Financial Corp. (“CI”) (TSX: CIX; NYSE: CIXX) will release its financial results for the second quarter of fiscal 2022 on Thursday, August 11, 2022.
CI will hold a conference call with
Granite REIT Declares Distribution for July 2022
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2583 per stapled unit for the month of
Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and Performance
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced
CI Global Asset Management Announces Risk Rating Changes for Three Funds
CI Global Asset Management (“CI GAM”) today announced risk rating changes for certain mutual funds, as follows:
Fund
New Rating
Previous Rating
Medium
CI Global Asset Management Announces July 2022 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending July 31, 2022 in respect of the CI ETFs. In all cases, the distribution will be paid on